← Leaderboards
Justin J Wilson
Cornell University
$2,523,433
Attributed
$2,523,433
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $566K · FY2019–24$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,523,433 · 3
By mechanism
R01$1,372,083 · 1
R21$619,180 · 1
R56$532,170 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Treatment Efficacy”
- Beth Baseler · Leidos Biomedical Research, Inc.$158,728,629
- Kimberly Smith · Ppd Development Lp$115,671,664
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Xinhua Li · Nano Terra, Inc.$35,520,438
- James Dale Berry · Brigham And Women'S Hospital$26,348,733
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
Research focus
Treatment EfficacyChelating AgentsPropertyRadiopharmaceuticalsVectorLigandsMetalsPenetrationRadioisotopesRadionuclide TherapyTumorLinear Energy TransferBeta ParticleAlpha ParticlesIonsBiologicalChemistryChelationCancer CellRadioactiveIn VivoComplexAlpha Particle EmitterBase
Grant awards (9)
Chelators to Enable Theranostic Alpha Particle Radiotherapeutic Agents$348,204
R56 · FY2024 · EB · contact PI
Chelators to Enable Theranostic Alpha Particle Radiotherapeutic Agents$183,966
R56 · FY2024 · EB · contact PI
Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapy$337,767
R01 · FY2023 · EB · contact PI
Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapy$336,382
R01 · FY2022 · EB · contact PI
Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapy$329,653
R01 · FY2021 · EB · contact PI
Expanding the Therapeutic Potential of the Alpha Emitter Radium-223$198,329
R21 · FY2021 · EB · contact PI
Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapy$368,281
R01 · FY2020 · EB · contact PI
Expanding the Therapeutic Potential of the Alpha Emitter Radium-223$197,739
R21 · FY2020 · EB · contact PI
Expanding the Therapeutic Potential of the Alpha Emitter Radium-223$223,112
R21 · FY2019 · EB · contact PI